GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » 5-Year Yield-on-Cost %

Hikma Pharmaceuticals (LSE:HIK) 5-Year Yield-on-Cost % : 5.13 (As of Apr. 30, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals 5-Year Yield-on-Cost %?

Hikma Pharmaceuticals's yield on cost for the quarter that ended in Dec. 2023 was 5.13.


The historical rank and industry rank for Hikma Pharmaceuticals's 5-Year Yield-on-Cost % or its related term are showing as below:

LSE:HIK' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.89   Med: 2.45   Max: 5.67
Current: 5.13


During the past 13 years, Hikma Pharmaceuticals's highest Yield on Cost was 5.67. The lowest was 0.89. And the median was 2.45.


LSE:HIK's 5-Year Yield-on-Cost % is ranked better than
80% of 500 companies
in the Drug Manufacturers industry
Industry Median: 2.175 vs LSE:HIK: 5.13

Competitive Comparison of Hikma Pharmaceuticals's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hikma Pharmaceuticals's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Hikma Pharmaceuticals's 5-Year Yield-on-Cost % falls into.



Hikma Pharmaceuticals 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Hikma Pharmaceuticals is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Hikma Pharmaceuticals  (LSE:HIK) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Hikma Pharmaceuticals 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hikma Pharmaceuticals (LSE:HIK) Business Description

Traded in Other Exchanges
Address
1 New Burlington Place, London, GBR, W1S 2HR
Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines